Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

430 public trials 126 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

NCT00406068

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • BCG Oncology Phoenix, Arizona, United States
  • San Diego Clinical Trials San Diego, California, United States
  • Connecticut Urological Research at Grove Hill New Britain, Connecticut, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 31 locations
View Trial Details
Completed

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

NCT00588666

Conditions
Bone Marrow Diseases, Cancer, Carcinoma, +9 more
Locations
  • Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

NCT00389155

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • Local Institution Concord, California, United States
View all 112 locations
View Trial Details
Completed

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

NCT00633789

Conditions
Adenocarcinoma Of Esophagus, Advanced Non-Small Cell Lung Cancer, Carcinoma, +10 more
Locations
  • University Of Chicago Chicago, Illinois, United States
  • Northshore Univ. Healthsystem Evanston, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 25 locations
View Trial Details

Related conditions